JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, NON-P.H.S.
Add like
Add dislike
Add to saved papers

Chest deflections and injuries in oblique lateral impacts.

A majority of laboratory-driven side-impact injury assessments are conducted using postmortem human subjects (PMHS) under the pure lateral mode. Because real-world injuries occur under pure and oblique modes, this study was designed to determine chest deflections and injuries using PMHS under the latter mode. Anthropometrical data were obtained and x-rays were taken. Specimens were seated on a sled and lateral impact acceleration corresponding to a change in velocity of 24 km/h was applied such that the vector was at an angle of 20 or 30 degrees. Chestbands were fixed at the level of the axilla (upper), xyphoid process (middle), and tenth rib (lower) location. Deflection contours as a function of time at the levels of the axilla and mid-sternum, representing the thorax, and at the tenth rib level, representing the abdomen, were evaluated for peak magnitudes. All data were normalized using mass-scaling procedures. Injuries were identified following the test at autopsy. Trauma graded according to the Abbreviated Injury Score, 1990 version, indicated primarily unilateral rib fractures and soft tissue abnormalities such as lung contusion and diaphragm laceration occurred. Mean peak deflections at the upper, middle, and lower levels of the chest for the 30-degree tests were 96.2, 78.5, and 76.8 mm. For the 20-degree tests, these magnitudes were 77.5, 89.9, and 73.6 mm. Statistical analysis indicated no significant (p > 0.05) differences in peak chest deflections at all levels between the two obliquities although the metric was significantly greater in oblique than pure lateral impacts at the mid and lower thoracic levels. These response data are valuable in oblique lateral impact assessments.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app